Trade Summary

2 days ago, KIRSKE DAVID, serving as Chief Financial Officer at X4 Pharmaceuticals, Inc (XFOR), sold 8,543 shares at $4.26 per share, for a total transaction value of $36,428.21. Following this transaction, KIRSKE DAVID now holds 167,750 shares of XFOR.

This sale represents a 4.85% decrease in KIRSKE DAVID's stake in the company. This is considered a medium-conviction trade.

The trade was executed on Tuesday, June 30, 2026 and publicly disclosed via SEC Form 4 filing on Wednesday, July 1, 2026 at 4:23 PM ET, 1 day after the trade was made.

X4 Pharmaceuticals, Inc operates in the HEALTHCARE sector, specifically within the BIOTECHNOLOGY industry. Insider selling activity in this sector can provide valuable signals about industry trends and company-specific developments.